Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rivey, M.
Right arrow Articles by Peterson, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rivey, M.
Right arrow Articles by Peterson, J.
American Journal of Hospital Pharmacy, Vol 50, Issue 2, 279-284
Copyright © 1993 by American Society of Health-System Pharmacists


Articles

Pharmacy-managed, weight-based heparin protocol

MP Rivey and JP Peterson


A revised protocol for heparin therapy, in which dosing was based on the patient's weight and the pharmacy staff assumed responsibility for management of the treatment protocol, was evaluated. A fixed-dose protocol for heparin therapy, in which an initial loading dose and infusion rate were specified by physicians and partial thromboplastin times (PTTs) were determined every 12 hours, was revised to determine dosing based on patient weight and diagnosis and to include more levels of dose adjustment and additional laboratory tests. Data on demographic characteristics of patients, heparin therapy, laboratory monitoring, conversion to warfarin therapy, and protocol management were collected for the patients receiving heparin under the revised protocol. Results were compared with those obtained for the old, fixed-dose protocol, which was managed by nursing staff. The revised protocol showed improvements in heparin therapy according to commonly accepted treatment criteria, including dosages, time to achieve a PTT associated with therapeutic anticoagulation, and the time a patient was in the target PTT range. The new protocol was also significantly more effective in avoiding low as well as high PTT ratios. The laboratory monitoring mandated by the revised protocol enhanced the monitoring of heparin therapy, and pharmacy management improved the accuracy and documentation of heparin therapy. Under the revised protocol, anticoagulation goals were attained more rapidly, and dosing changes were more likely to be correct and appropriately documented.
 



This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
W. E. Dager and M. P. Gulseth
Implementing anticoagulation management by pharmacists in the inpatient setting
Am. J. Health Syst. Pharm., May 15, 2007; 64(10): 1071 - 1079.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. A. Kalafut, R. Gandhi, C. S. Kidwell, and J. L. Saver
Safety and Cost of Low-Molecular-Weight Heparin as Bridging Anticoagulant Therapy in Subacute Cerebral Ischemia
Stroke, November 1, 2000; 31(11): 2563 - 2568.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
T. Hodgman
A Review of Common Approaches to Heparin Dosing
Journal of Pharmacy Practice, February 1, 1995; 8(1): 39 - 46.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Society of Health-System Pharmacists.